Protalix BioTherapeutics (PLX) Other Working Capital Changes (2017 - 2024)

Protalix BioTherapeutics has reported Other Working Capital Changes for 12 years, with the latest figure at -$38000.0 in Q3 2021.

• On a quarterly basis, Other Working Capital Changes rose 51.28% year-over-year to -$38000.0 in Q3 2021; TTM through Dec 2021 was -$51000.0, a 88.86% increase from a year earlier, with the FY2021 full-year figure at -$51000.0, up 88.86% from the prior year.
• Other Working Capital Changes was -$38000.0 for Q3 2021 at Protalix BioTherapeutics, down from $12000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $16.0 million in Q2 2021, with the low at -$11.8 million in Q2 2023.
• Average Other Working Capital Changes over 5 years is -$1.4 million, with a median of -$2.6 million recorded in 2022.
• The sharpest annual moves came in 2017 and 2020: Other Working Capital Changes jumped 1422.5% in 2017, then plunged 14850.0% in 2020.
• Over 5 years, Other Working Capital Changes stood at $1.6 million in 2017, then sank by 154.32% to -$862000.0 in 2018, then jumped by 34.8% to -$562000.0 in 2019, then surged by 100.89% to $5000.0 in 2020, then sank by 860.0% to -$38000.0 in 2021.
• The last three Other Working Capital Changes figures came in at -$38000.0 (Q3 2021), $12000.0 (Q2 2021), and -$25000.0 (Q1 2021), per Business Quant data.